Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)

Bernard Chevalier1*, MD; Angel Cequier2, MD; Dariusz Dudek3, MD; Michael Haude4, MD; Didier Carrie5, MD, PhD; Manel Sabaté6, MD, PhD; Stephan Windecker7, MD, PhD; Sebastian Reith8, MD; Manuel de Sousa Almeida9, MD, PhD; Gianluca Campo10, MD; Andres Iñiguez11, MD; Yoshi Onuma12, MD, PhD; Patrick W. Serruys13, MD, PhD